90 related articles for article (PubMed ID: 22318511)
1. Global cardiovascular risk associated with hypertension and extent of treatment and control according to risk group.
Wong ND; Dede J; Chow VH; Wong KS; Franklin SS
Am J Hypertens; 2012 May; 25(5):561-7. PubMed ID: 22318511
[TBL] [Abstract][Full Text] [Related]
2. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004.
Wong ND; Lopez VA; L'Italien G; Chen R; Kline SE; Franklin SS
Arch Intern Med; 2007 Dec; 167(22):2431-6. PubMed ID: 18071164
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States.
Wong ND; Lopez V; Tang S; Williams GR
Am J Cardiol; 2006 Jul; 98(2):204-8. PubMed ID: 16828593
[TBL] [Abstract][Full Text] [Related]
4. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.
Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722
[TBL] [Abstract][Full Text] [Related]
6. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
[TBL] [Abstract][Full Text] [Related]
7. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
[TBL] [Abstract][Full Text] [Related]
8. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults.
Ghandehari H; Le V; Kamal-Bahl S; Bassin SL; Wong ND
Int J Obes (Lond); 2009 Feb; 33(2):239-48. PubMed ID: 19050677
[TBL] [Abstract][Full Text] [Related]
9. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
10. Influence of pre-hypertension on all-cause and cardiovascular mortality: the Singapore Cardiovascular Cohort Study.
Lee J; Heng D; Ma S; Chew SK; Hughes K; Tai ES
Int J Cardiol; 2009 Jul; 135(3):331-7. PubMed ID: 18582967
[TBL] [Abstract][Full Text] [Related]
11. Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study.
Lee J; Ma S; Heng D; Chew S; Hughes K; Tai E
J Hum Hypertens; 2008 Jul; 22(7):468-74. PubMed ID: 18337755
[TBL] [Abstract][Full Text] [Related]
12. [Arterial hypertension management in general practice in France according to global risk factors].
Amar J; Vaur L; Perret M; Bailleau C; Etienne S; Chamontin B
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):843-5. PubMed ID: 11575215
[TBL] [Abstract][Full Text] [Related]
13. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
Colvine K; Kerr AJ; McLachlan A; Gow P; Kumar S; Ly J; Wiltshire C; Robinson E; Dalbeth N
N Z Med J; 2008 Nov; 121(1285):73-81. PubMed ID: 19079439
[TBL] [Abstract][Full Text] [Related]
15. SCORE model underestimates cardiovascular risk in hypertensive patients: results of the Polish Hypertension Registry.
Szyndler A; Kucharska WA; Dubiela-D Browska AE; Olszanecka A; Widecka J; B Czkiewicz MA; Widecka K; Galas GY; Chlebi Ska I; Sakiewicz W; Gaciong Z; Widecka K; Januszewicz A; Kawecka-Jaszcz K; Narkiewicz K;
Blood Press; 2011 Dec; 20(6):342-7. PubMed ID: 21675828
[TBL] [Abstract][Full Text] [Related]
16. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
17. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
18. Exercise and cardiovascular outcomes by hypertensive status: NHANES I epidemiological follow-up study, 1971-1992.
Fang J; Wylie-Rosett J; Alderman MH
Am J Hypertens; 2005 Jun; 18(6):751-8. PubMed ID: 15925731
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of abnormal ankle-brachial index among individuals with low or intermediate Framingham Risk Scores.
Dhangana R; Murphy TP; Coll JR; Ahn SH; Zafar AM; Qadeer FF; Hiatt WR
J Vasc Interv Radiol; 2011 Aug; 22(8):1077-82. PubMed ID: 21705232
[TBL] [Abstract][Full Text] [Related]
20. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
